Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
more information about the study results is available, it can also be found here.
X www.clinicaltrials.gov Once you are on the website, type “NCT03555994”
into the search box and click “Search”.
X www.clinicaltrialsregister.eu Once you are on the website, click “Home
and Search”, then type “2017-005081-22” in the search box and click
“Search”.
X www.AstraZenecaClinicalTrials.com Once you are on the website, type
“D5670C00022” into the search box and click “Find a Study”.
Full Study Title: An Exploratory Phase 2, Randomised, Double-blind, Placebo-
controlled, and Open-label Active Comparator Study to Evaluate the Effect of
MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects
with Type 2 Diabetes Mellitus
AstraZeneca Protocol Number: D5670C00022
National Clinical Trials Number: NCT03555994
EudraCT Number: 2017-005081-22
AstraZeneca UK sponsored this study and has its headquarters in Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take
part in clinical research around the world. They help researchers answer
important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about clinical research participation. CISCRP is not involved
in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2022_04_06
12 | Clinical Study Results